Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
13/07/2020 13:10
July 13 (Reuters) - Helix Biopharma Corp HBP.TO :
* HELIX BIOPHARMA CORP - INTENDS TO FILE INTERIM
CONSOLIDATED
FINANCIAL STATEMENTS BY JULY 30
Source text for Eikon: ID:nGNX3cx8DD
Further company coverage: HBP.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020